Prenatal methamphetamine exposure
Related entities
Findings (50)
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating
Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8
None
declinePrenatal methamphetamine exposure was associated with increased slope of reaction time across blocks on the K-CPT, indicating greater vigilance decline as the test progressed, consistent with attentio
Effect: decline
None
declinePrenatal methamphetamine exposure was associated with increased slope of reaction time across blocks on the K-CPT, indicating greater vigilance decline as the test progressed, consistent with attentio
Effect: decline
None
declinePrenatal methamphetamine exposure was associated with increased slope of reaction time across blocks on the K-CPT, indicating greater vigilance decline as the test progressed, consistent with attentio
Effect: decline
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
nullPrenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for
Effect: null
None
declinePrenatal methamphetamine exposure was associated with increased variability in reaction time with longer interstimulus intervals on the K-CPT, indicating less consistent attention when the child has t
Effect: decline
None
declinePrenatal methamphetamine exposure was associated with increased variability in reaction time with longer interstimulus intervals on the K-CPT, indicating less consistent attention when the child has t
Effect: decline